Molecular Dynamics Simulation Study of PEG–PCL nanoparticles for BCNU delivery to treat glioblastoma
Abstract
Author(s): Sina Ramezani, Samira poulakchi Sabe, Zahra Jamalpoor
Glioblastoma, The most lethal form of brain cancer is characterized by rapid growth and invasion and poor survival of the patients. Despite advances in standard therapy, including surgical resection followed by radiation and chemotherapy, glioblastoma remains highly resistant to treatments. Thus, new approaches to design optimized therapies are needed. Poly(ethylene glycol)-poly(ε-caprolactone) (PEG-PCL) copolymers are synthetic biomedical materials with high biocompatibility, biodegradability, long circulating and enhanced drug accumulation at the site of action that are all suitable for long-term delivery. In this study, we carried out Molecular Dynamics simulation on PEG-PCL2 to investigate the ability of this nanoparticle as drug carrier for BCNU. Simulation results indicated that PEG-PCL2 aggregated and formed stable nanoparticles with the average radius of gyration of 2nm. Also plots represented that BCNU penetrated deep into the micelles. In conclusion, observations confirmed that the PEG-PCL nanoparticles have potentials to be used as BCNU delivery carriers.
Share this article
Editors List
-
Prof. Elhadi Miskeen
Obstetrics and Gynaecology Faculty of Medicine, University of Bisha, Saudi Arabia
-
Ahmed Hussien Alshewered
University of Basrah College of Medicine, Iraq
-
Sudhakar Tummala
Department of Electronics and Communication Engineering SRM University – AP, Andhra Pradesh
-
Alphonse Laya
Supervisor of Biochemistry Lab and PhD. students of Faculty of Science, Department of Chemistry and Department of Chemis
-
Fava Maria Giovanna
Onkologia i Radioterapia peer review process verified at publons
Indexed In
- Directory of Open Access Journals
- Scimago
- SCOPUS
- EBSCO A-Z
- MIAR
- Euro Pub
- Google Scholar
- Medical Project Poland
- PUBMED
- Cancer Index
- Gdansk University of Technology, Ministry Points 20